BMS 470539 Dihydrochloride
CAS: 457893-92-4
Ref. 3D-HTA89392
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Informação sobre produto
- 1-Butanone, 1-[1-(3-methyl-<span class="text-smallcaps">L</smallcap>-histidyl-O-methyl-<smallcap>D</span>-tyrosyl)-4-phenyl-4-piperidinyl]-
- 1-[1-(3-Methyl-<span class="text-smallcaps">L</smallcap>-histidyl-O-methyl-<smallcap>D</span>-tyrosyl)-4-phenyl-4-piperidinyl]-1-butanone
- 1H-Imidazole-5-propanamide, α-amino-N-[(1R)-1-[(4-methoxyphenyl)methyl]-2-oxo-2-[4-(1-oxobutyl)-4-phenyl-1-piperidinyl]ethyl]-1-methyl-, (αS)-
- Bms 470539
- N1-[2-(4-Butyryl-4-phenylpiperidin-1-yl)-1(R)-(4-methoxybenzyl)-2-oxoethyl]-Ntau-methyl-L-histidinamide
BMS 470539 Dihydrochloride is a humanized anti-inflammatory monoclonal antibody that inhibits tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β). This drug is used for the treatment of eye disorders, bowel disease, and other conditions. BMS 470539 Dihydrochloride binds to TNF receptors and blocks the interaction between TNF-α or IL-1β with their receptors, which prevents the production of inflammatory cytokines. This drug also has neuroprotective effects in animal studies. It is believed that this effect may be due to inhibition of microglial activation, which are cells in the central nervous system that release inflammatory cytokines. The molecule does not bind to macrophages or erythrocytes, so it does not have an effect on platelet aggregation or coagulation.
Propriedades químicas
Consulta técnica sobre: 3D-HTA89392 BMS 470539 Dihydrochloride
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
